Soluble galectin-3 is a strong, colonic epithelial-cell-derived, lamina propria fibroblast-stimulating factor
- PMID: 16709662
- PMCID: PMC1856646
- DOI: 10.1136/gut.2005.081646
Soluble galectin-3 is a strong, colonic epithelial-cell-derived, lamina propria fibroblast-stimulating factor
Abstract
Background: Colonic lamina propria fibroblasts (CLPFs) play an important role in the pathogenesis of fibrosis and strictures in Crohn's disease.
Aim: To identify colonic epithelial cell (CEC)-derived factors that activate CLPFs.
Methods: Primary human CECs and CLPFs were isolated from control mucosa and interleukin 8 (IL8) of CLPF cultures was quantified by ELISA. Activation of nuclear factor kappaB (NF-kappaB) was shown, and translocation of NF-kappaB was inhibited by a dominant-negative IkappaB-expressing adenovirus. The major CLPF-activating and IL8 inducing protein was purified using fast-performance liquid chromatography (HiPrep 16/60 Sephacryl S-200 High Resolution Column) and sodium dodecyl sulphate gel electrophoresis.
Results: A considerable increase in IL8 secretion by CLPFs cultured in CEC-conditioned media compared with that in unconditioned media (155.00 (10.00) pg/microg v 1.434 (0.695) pg/microg) was found. The effect of CEC-conditioned media on CLPF IL8 secretion was NF-kappaB dependent. A protein or DNA array confirmed the involvement of NF-kappaB and activator protein-1. Purification of a candidate band isolated with the use of sodium dodecyl sulphate-polyacrylamide gel electrophoresis and subsequent sequencing showed soluble galectin-3 to be a strong CLPF-activating factor. Depletion of galectin-3 from conditioned media by immunoprecipitation abolished the CLPF stimulatory effect.
Conclusions: Using a classical biochemical approach, soluble galectin-3 was identified as a strong activator of CLPFs produced by CEC. Galectin-3 induced NF-kappaB activation and IL8 secretion in these cells and may be a target for future therapeutic approaches to reduce or avoid stricture formation.
Conflict of interest statement
Competing interests: None declared.
References
-
- Gillitzer R, Goebeler M. Chemokines in cutaneous wound healing. J Leukoc Biol 200169513–521. - PubMed
-
- Tranquillo R T, Murray J D. Mechanistic model of wound contraction. J Surg Res 199355233–247. - PubMed
-
- Nedelec B, Ghahary A, Scott P G.et al Control of wound contraction. Basic and clinical features. Hand Clin 200016289–302. - PubMed
-
- Rogler G, Gelbmann C M, Vogl D.et al Differential activation of cytokine secretion in primary human colonic fibroblast/myofibroblast cultures. Scand J Gastroenterol 200136389–398. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials